Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_1
3
60%
Ph not_applicable
1
20%

Phase Distribution

3

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Other(4)

Detailed Status

unknown4
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (60.0%)
Phase 21 (20.0%)
N/A1 (20.0%)

Trials by Status

unknown480%
completed120%

Recent Activity

0 active trials
Showing 5 of 5
unknownnot_applicable

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

NCT00079365
unknownphase_1

Brachytherapy in Treating Patients With Recurrent Prostate Cancer

NCT00005939
unknownphase_1

Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

NCT00004129
unknownphase_1

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

NCT00006212
completedphase_2

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

NCT00002689

Clinical Trials (5)

Showing 5 of 5 trials
NCT00079365Not Applicable

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

Unknown
NCT00005939Phase 1

Brachytherapy in Treating Patients With Recurrent Prostate Cancer

Unknown
NCT00004129Phase 1

Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

Unknown
NCT00006212Phase 1

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Unknown
NCT00002689Phase 2

Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer

Completed

All 5 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
5